220100.KQ Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
03:00
May 04
May 04
Prostate cancer approval catalyst
Futurechem received domestic approval for its prostate cancer treatment after a long delay. The stock has bottomed and is expected to improve from here.
MED
About 220100.KQ Analyst Coverage
Buzzberg tracks 220100.KQ across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked.